Literature DB >> 17719641

Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152.

Franz Grehn, Gábor Holló, Peng Khaw, Barry Overton, Rosamund Wilson, Roger Vogel, Zaid Smith.   

Abstract

PURPOSE: To determine the factors affecting trabeculectomy success.
DESIGN: Retrospective analysis of 2 randomized controlled trials comparing an antibody against transforming growth factor beta2 (TGF-beta2) with vehicle (placebo) for prevention of fibrosis after trabeculectomy, in which there was no significant difference between the treatment groups. PARTICIPANTS: Data were from patients (n = 726) with a diagnosis of primary open-angle glaucoma, chronic angle-closure glaucoma, pseudoexfoliative glaucoma, or pigmentary glaucoma (PG) who had an intraocular pressure (IOP) > 21 mmHg and visual field or optic disc changes characteristic of glaucoma and were taking the maximum tolerated dose of medication before trabeculectomy.
METHODS: Patients had trabeculectomy and 4 subconjunctival injections of a human monoclonal antibody to TGF-beta2 (CAT-152) or a placebo. The definition of trabeculectomy success in the protocols was an IOP between 6 and 16 mmHg inclusive at months 6 and 12. Analyses of success used factors identified by ophthalmic experts. MAIN OUTCOMES MEASURES: Covariates analyzed included patient age, black race, gender, time since diagnosis, primary diagnosis, country, diabetes, mean defect, cup-to-disc (C/D) ratio, suture type, anesthetic, flap type, IOP at listing for surgery, suture release/lysis, needling, reformed anterior chamber, wound leak, severe bleb vascularity, and bleb microcysts.
RESULTS: A stepwise logistic regression model found the following predictors of treatment success: PG (odds ratio [OR], 4.11; 95% confidence interval [CI], 1.41-11.99), high C/D ratio (OR, 2.84; 95% CI, 1.15-6.99), and use of a corneal traction suture (OR, 1.67; 95% CI, 1.09-2.56). A negative relationship was found for black race (OR, 0.28; 95% CI, 0.13-0.62); treatment in France (OR, 0.35; 95% CI, 0.17-0.70), Sweden (OR, 0.17; 95% CI, 0.05-0.58), Spain (OR, 0.37; 95% CI, 0.21-0.68), Poland (OR, 0.53; 95% CI, 0.32-0.88), or Hungary (OR, 0.14; 95% CI, 0.06-0.34); and suture release/lysis (OR, 0.34; 95% CI, 0.22-0.53). The effect of needling was marginally statistically significant (OR, 0.56; 95% CI, 0.31-1.01).
CONCLUSIONS: Successful trabeculectomy outcome was associated with PG, higher C/D ratio, and corneal traction suturing. Factors associated with surgical failure were black race and suture release/lysis. Intercountry differences also were observed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719641     DOI: 10.1016/j.ophtha.2007.06.028

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  18 in total

1.  [Modern filtration surgery. An update].

Authors:  T Klink; F Grehn
Journal:  Ophthalmologe       Date:  2013-04       Impact factor: 1.059

Review 2.  Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.

Authors:  Daisy Y Shu; Frank J Lovicu
Journal:  Prog Retin Eye Res       Date:  2017-08-12       Impact factor: 21.198

Review 3.  Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.

Authors:  Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

Review 4.  Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.

Authors:  Megan Kim; Chelsea Lee; Rachael Payne; Beatrice Y J T Yue; Jin-Hong Chang; Hongyu Ying
Journal:  Surv Ophthalmol       Date:  2015-05-15       Impact factor: 6.048

5.  Restricted post-trabeculectomy bleb formation by conjunctival scarring.

Authors:  Keiichiro Iwao; Masaru Inatani; Minako Ogata-Iwao; Yuji Takihara; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-12       Impact factor: 3.117

6.  Inflammatory molecules in aqueous humour and on ocular surface and glaucoma surgery outcome.

Authors:  Barbara Cvenkel; Andreja Natasa Kopitar; Alojz Ihan
Journal:  Mediators Inflamm       Date:  2010-05-05       Impact factor: 4.711

7.  The moorfields safer surgery system.

Authors:  Sumit Dhingra; Peng T Khaw
Journal:  Middle East Afr J Ophthalmol       Date:  2009-07

8.  Influence of high myopia on outcomes of trabeculectomy with mitomycin C in patients with primary open-angle glaucoma.

Authors:  Daisuke Tanaka; Hideo Nakanishi; Masanori Hangai; Tadamichi Akagi; Satoshi Morooka; Hanako Ohashi Ikeda; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2016-08-12       Impact factor: 2.447

9.  Animal models of scarring control.

Authors:  David L Williams
Journal:  Eye (Lond)       Date:  2019-12-10       Impact factor: 3.775

10.  TGF-beta-induced interleukin-6 participates in transdifferentiation of human Tenon's fibroblasts to myofibroblasts.

Authors:  Gong Je Seong; Samin Hong; Sun-Ah Jung; Jung-Jin Lee; Eunhae Lim; Sung-Joo Kim; Joon H Lee
Journal:  Mol Vis       Date:  2009-10-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.